November 29th, 2023
Obatala Sciences Announces Commercial Launch of Its ObaCell® Obesity-on-a-Chip Service
New technology will enable improved development of obesity and diabetes treatments.
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag:
October 12th, 2023
Harvard enters into Collaboration with Novo Nordisk and Evotec to launch LAB eN², a translational drug discovery accelerator
Harvard University joins Mass General Brigham, Yale University, and Beth Israel Deaconess Medical Center as the initial four academic institutions to participate in LAB eN².
September 13th, 2023
Engineered Serendipity
Two electrical engineers took a fresh approach to drug discovery, merging semiconductors with cellular biology.
August 16th, 2023
Citadel Securities and Google Cloud Announce High Performance Computing Study with Harvard University to Advance Heart Disease Research
Professor Petros Koumoutsakos Leading Study to Replicate Supercomputer Resources in Public Cloud.
July 25th, 2023
E-nose sniffs out harmful molecules
AI-enabled portable sensor can be used to manage hazardous waste, monitor air quality, identify spoiled food, and diagnose diseases.
